Cytokinetics Incorporated (CYTK) Declined -6.82% or -0.52 To Price $7.11 On Thursday

Cytokinetics Incorporated (CYTK) declined -6.82% or -0.52 to $7.11. It is close to 245602 shares traded, which is 62.05% compare to the average total volume 395784. The market cap of CYTK is $388.41 million. The year to date change is -19.62%. The 52 week price range is from $6.21 to $12.72. Price of CYTK have changed 10.10% during last week. It have changed -7.06% over last month, 7.46% over last 3 months, -11.79% over last 6 months and -37.46% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYTK is 7.94. It is 11.67% above current price. The 200-day Moving Averages for CYTK is 8.16. It is 14.77% above current price. The 52-week High is 12.72. It is 78.90% from the current price. The 52-week Low is 6.21. It is -12.66% from current price.

There are some statistics of CYTK. It is has market cap $388.41 million. The share outstanding is 54.63 million. The average volume is 395784. The revenue is -18000. The percent of top 15 Institution holding is 51.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYTK is -116.63%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYTK is -41.66%.


Share this post